A detailed history of Kathmere Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Kathmere Capital Management, LLC holds 3,919 shares of LLY stock, worth $3.32 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
3,919
Previous 3,986 1.68%
Holding current value
$3.32 Million
Previous $3.61 Million 3.8%
% of portfolio
0.34%
Previous 0.39%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $51,733 - $64,321
-67 Reduced 1.68%
3,919 $3.47 Million
Q2 2024

Jul 17, 2024

SELL
$724.87 - $909.04 $641,509 - $804,500
-885 Reduced 18.17%
3,986 $3.61 Million
Q2 2024

Jul 01, 2024

BUY
$724.87 - $909.04 $162,370 - $203,624
224 Added 4.82%
4,871 $4.41 Million
Q1 2024

Apr 16, 2024

SELL
$592.2 - $792.28 $132,652 - $177,470
-224 Reduced 4.6%
4,647 $3.62 Million
Q4 2023

Apr 16, 2024

BUY
$525.19 - $619.13 $1,050 - $1,238
2 Added 0.04%
4,871 $2.84 Million
Q3 2023

Oct 11, 2023

BUY
$434.7 - $599.3 $324,286 - $447,077
746 Added 18.09%
4,869 $2.62 Million
Q2 2023

Jul 11, 2023

BUY
$350.74 - $468.98 $15,783 - $21,104
45 Added 1.1%
4,123 $1.93 Million
Q1 2023

Apr 20, 2023

SELL
$310.63 - $364.82 $157,800 - $185,328
-508 Reduced 11.08%
4,078 $1.4 Million
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $30,868 - $35,968
96 Added 2.14%
4,586 $0
Q4 2022

Jan 24, 2023

BUY
$321.55 - $374.67 $314,154 - $366,052
977 Added 27.81%
4,490 $0
Q3 2022

Oct 11, 2022

BUY
$296.48 - $337.87 $243,706 - $277,729
822 Added 30.55%
3,513 $1.14 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $362,070 - $425,123
1,299 Added 93.32%
2,691 $873,000
Q1 2022

Apr 28, 2022

SELL
$234.69 - $291.66 $238,210 - $296,034
-1,015 Reduced 42.17%
1,392 $399,000
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $351,951 - $407,095
2,407 New
2,407 $356,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $805B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Kathmere Capital Management, LLC Portfolio

Follow Kathmere Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kathmere Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kathmere Capital Management, LLC with notifications on news.